Home

What Are Clinical Trials ?

Active Clinical Trials

•   Brain Metastases

•   Newly Diagnosed
    Gliobastoma
    Multiforme (GBM)
    RTOG 0513

•   Newly Diagnosed
    Gliobastoma
    Multiforme (GBM)
    RTOG 0525

•   Recurrent  
    Gliobastoma 
    Multiforme (GBM)
    RTOG 0625

•   Recurrent  
    Gliobastoma 
    Multiforme (GBM)
    RTOG 0627

ACTIVE CLINICAL TRIALS

BRAIN METASTASES FROM LUNG PRIMARY

 A PHASE II STUDY TO DETERMINE THE EFFICACY OF TARCEVA (ERLOTINIB HYDROCHLORIDE) WITH CONCURRENT WHOLE BRAIN RADIATION THERAPY IN PATIENTS WITH BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER

 Eligibility Criteria

• At least 18 years of age

• Histological confirmation of non-small cell lung cancer

• No evidence of liver metastases

Please contact Jamie Holt at 626-6800 
for further information.